Stent Summit 2022
Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas, facilitating safe and effective drug development for personalized and targeted patient populations. The company is known for organizing high-profile events such as the iPSC Drug Development Summit, which unites leaders in the field to advance the development of genetically stable and clinically efficacious iPSC cell therapies.
With a focus on optimizing processes from research and development through to commercialization, Hanson Wade provides actionable insights and strategies for overcoming challenges in iPSC therapy development. Their events feature world-class speakers and foster collaboration among industry experts to drive innovation in therapeutic applications spanning oncology, neurology, immunology, and regenerative medicine.
Generated from the website